Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC
NSCLC is the leading cause of cancer deaths globally, with EGFR mutations being a common feature in these cancers.
Bang Yu Key Laboratory Of Quality Research University Of Macau Institute Of Chinese Medical Sciences State Key Laboratory Quality Research
Source: news-medical.net